⚡ JavaScript disabled! ⚡⚡ Unsupported browser! Works best in modern browsers. ⚡
NameLast modifiedSize
folder-parentParent Directory
default2017 circulating tumor cells - Greece 2017-02-13.pdf2017-02-13 08:41551 KB
default2018 Assessing the Diagnostic Value of Plasma-Free DNA in Prostate Cancer Screening.pdf2018-07-05 09:04630 KB
default2019 Identification and monitoring of somatic mutations in circulating cell-free.pdf2020-01-06 09:534347 KB
default2019 The potential of serum fetal DNA for early diagnosis of gestational trophoblastic disease-2020.pdf2020-03-18 09:08422 KB
default2020 Clinical Utility of Plasma KRAS, NRAS and BRAF Mutational Analysis with Real Time PCR in Metastatic Colorectal Cancer Patients-The Importance of TissuePlasma Discordant Cases.pdf2021-01-19 07:281284 KB
default2020 Clinical Utility of Plasma KRAS, NRAS and BRAF Mutational Analysis with Real Time PCR in Metastatic Colorectal Cancer Patients—The Importance of TissuePlasma Discordant Cases.pdf2021-01-20 08:411284 KB
default2022 Optimized Droplet Digital PCR Assay on Cell-Free DNA Samples for Non-Invasive Prenatal Diagnosis Application to Beta-Thalassemia.pdf2022-09-21 08:27735 KB
default2023 A Case-Control Study by ddPCR of ALU 260111 and LINE-1 26697 Copy Number Ratio in Circulating Cell-Free DNA in Plasma Revealed LINE-1 26697 as a Potential Biomarker for Early Breast Cancer Detection.pdf2023-07-02 07:501563 KB
default2023 Epigenetic modifications associated with prognosis and treatment response in patients with advanced ovarian cancer.pdf2024-01-19 04:052039 KB
default2023 Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of EZH2 mutations in follicular lymphoma.pdf2023-07-02 07:472416 KB
default2024 Mitochondrial Fraction of Circulating Cell-Free DNA as an Indicator of Human Pathology.pdf2024-06-17 06:212842 KB
default2024 Prognostic significance of BRCA1 and BRCA2 methylation status in circulating cell-free DNA of Pancreatic Cancer patients.pdf2024-06-17 06:212167 KB